marijuana stocks news

Medbox Appoints Tim Morrissey as V.P. and Director of Vaporfection

Morrissey Built the #1 Vaporizer Brand With $8.5 Million in Sales in in the first year.

LOS ANGELES, Oct. 30, 2014 /PRNewswire/ — Medbox, Inc. (MDBX) (www.medbox.com), a leading dispensary infrastructure/licensing specialist, patented technology provider, and partner to the cannabis industry, is proud to announce the addition of Tim Morrissey to lead Medbox’s wholly owned subsidiary, Vaporfection International, Inc., as Director and Vice-President.

Mr. Morrissey is the founder and Chief Executive Officer of Head Choice Inc., which is involved in many facets of the vaporization industry including consultation, manufacturing, sales and distribution.  Its brands include the Da Buddha vaporizer, the Silver Surfer vaporizer, the Journey 2 and Journey 3 and most recently the Pax by Ploom. Mr. Morrissey’s involvement with the Pax ranged from overseeing early stage design concepts, beta testing and marketing plans, to aiding in elements of overseas manufacturing, the original launch, and sales into more than 5,000 stores nationwide. Mr. Morrissey speaks both Cantonese, and Mandarin Chinese and owns his own factory in Guangzhou China. Mr. Morrissey has also successfully built a hemp and recycled polyester bag company, Dragons Breath LLC, whose products are among the most recognized in the smoking accessories industry. Some of these successes have come from working with vaporizer companies to produce their own co-branded carrying cases for many of the vaporizers in the market today.

“I’m pleased to have someone with Tim’s background and skills leading Vaporfection International, especially as we roll out our exciting new portable vaporizer, the miVape,” commented Guy Marsala, CEO at Medbox, Inc. “This is yet another key development in the maturation process of Medbox’s leadership team and business model.”

Mr. Morrissey stated, “In 2012 and 2013 my company was selected to be the exclusive distributor of the Pax vaporizer and had the most successful launch of a product into the specialty smoking industry. I am now setting my sights on the Vaporfection award-winning line of products that feature patented glass-on-glass heating and a host of features patients and consumers will undoubtedly enjoy. I am ecstatic that Medbox has chosen me to lead this brand and I will do my part to bring value to the company and its shareholders.”

Management commented that the new miVape portable vaporizer that is being launched in December of this year is anchored by four new design and utility patents issued earlier this year (D708,727 S; 8,739,786 B2; US 8,739,787 B2; and US 8,739,788 B2).

About Medbox, Inc: 

Medbox (https://www.medbox.com) is the leading dispensary infrastructure and licensing specialist, patented technology provider, and partner to the cannabis industry. Headquartered in Los Angeles, CA, Medbox, through its wholly owned subsidiary, Medicine Dispensing Systems, offers its patented systems, software and consulting services to pharmacies, alternative medicine dispensaries and local governments in the U.S. In addition, through its wholly owned subsidiary, Vaporfection International, Inc. (www.vaporfection.com), the company offers an industry award winning line of medical vaporizer products. Medbox, through its newly established subsidiaries, is also developing ancillary services tailored to the alternative medicine industry, including: real estate acquisitions and subsequent lease programs to alternative medicine dispensaries and cultivation centers, and alternative medicine dispensary and cultivation management services.

Forward-Looking Statements:

Statements in this press release constitute forward-looking statements within the meaning of federal securities laws. Such statements are based on our current beliefs and expectations and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond our control. In addition, such forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. Potential risks and uncertainties include, but are not limited to, technical advances in the industry as well as political and economic conditions present within the industry. We do not take any obligation to update any forward-looking statement to reflect events or developments after a forward-looking statement was made.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

AbbVie Inc. (ABBV) and Scripps Research Announce Collaboration to Develop Antiviral Treatments for COVID-19

AbbVie and Scripps Research Announce Collaboration to Develop Antiviral Treatments for COVID-19…

Ayr Wellness Inc. (AYRWF) Announces the Launch of Kynd Premium Flower in Florida

Ayr Wellness Announces the Launch of Kynd Premium Flower in Florida Ayr…

$OGRMF Income Statement

OrganiGram Holdings Inc. (OGRMF)   Income Statement Get Income Statement for: View:…

Tetra Bio-Pharma Inc. (TBPMF) Receives its 4th FDA Orphan Drug Designation

Tetra Receives its 4th FDA Orphan Drug Designation Tetra Bio-Pharma Inc. (“Tetra”…